The CD 1 Individual Career Development Support (ICDS) Program will provide individualized training that is focused on advanced post-doctoral and professional degree scientists, junior or senior faculty, or other health professionals who seek career opportunities in biodefense and emerging diseases research. All Individual Trainees will also be encouraged to take part in the Group Training activities (CD 2.1 Group Product Development Training and CD 2.2 Group Biosafety Level 3 Training), and certain Individual Trainees might even decide to focus their research on Product Development or Biosafety. The research projects will exploit the extraordinary expertise and facilities available in Region VIII concerning research on bacterial and viral Category A -C priority pathogens or emerging pathogens, and they will integrate with, complement, and enhance the overall mission of the RMRCE. The goals of this program will be achieved through the following Specific Aims: * To identify and recruit the "best and brightest" scientists and health professionals. * To assist recruits, when needed, in identifying mentors who can provide the expertise and resources for the desired training in biodefense or EID research (including basic and translational research, product development and biosafety). ? To assist Mentors by identifying and providing resources that can aid the trainees in developing their careers (e.g., information on NIH workshops and trainee-appropriate funding opportunities). * To conduct Outcomes Assessment through semi-annual reports and annual reports, and to track the careers of ICDS program "alumni" through agreed-upon modes of contact (e.g., e-mail, phone, letter). * To continuously monitor the progress of trainees and the success of the trainee/mentor relationship by maintaining regular, informal communication with both the trainee and the mentor. The Individual Career Development Support Program directly supports the RMRCE's objective of providing trained personnel for biodefense and emerging infectious diseases research. Most if not all of the trainees will work in the laboratories of RMRCE-funded Pis, and will thus contribute to the successful attainment of research project goals. The working relationship between each trainee and the projects/cores of the RMRCE will depend on the Mentor and the aims of the Trainee's research project.

Public Health Relevance

The CD 1 Individual Career Development Support Program of the RMRCE will address the NIH objective of training a sufficient number of scientists and health professionals with expertise in biodefense and emerging infectious diseases research. These types of researchers will contribute to the discovery and development of vaccines, detection tests, antibiotics and drugs to treat disease outbreaks of public health importance, regardless of whether such outbreaks are intentional or naturally-occurring.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-DDS-M)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Colorado State University-Fort Collins
Fort Collins
United States
Zip Code
Gibson, Christopher C; Zhu, Weiquan; Davis, Chadwick T et al. (2015) Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation. Circulation 131:289-99
Wang, Hong; Siddharthan, Venkatraman; Hall, Jeffery O et al. (2014) Autonomic deficit not the cause of death in West Nile virus neurological disease. Clin Auton Res 24:15-23
Scharton, Dionna; Bailey, Kevin W; Vest, Zachary et al. (2014) Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment. Antiviral Res 104:84-92
Shives, Katherine D; Beatman, Erica L; Chamanian, Mastooreh et al. (2014) West nile virus-induced activation of mammalian target of rapamycin complex 1 supports viral growth and viral protein expression. J Virol 88:9458-71
Calvert, Amanda E; Dixon, Kandice L; Delorey, Mark J et al. (2014) Development of a small animal peripheral challenge model of Japanese encephalitis virus using interferon deficient AG129 mice and the SA14-14-2 vaccine virus strain. Vaccine 32:258-64
Richert, Laura E; Rynda-Apple, Agnieszka; Harmsen, Ann L et al. (2014) CD11cýýý cells primed with unrelated antigens facilitate an accelerated immune response to influenza virus in mice. Eur J Immunol 44:397-408
Soffler, Carl; Bosco-Lauth, Angela M; Aboellail, Tawfik A et al. (2014) Pathogenesis of percutaneous infection of goats with Burkholderia pseudomallei: clinical, pathologic, and immunological responses in chronic melioidosis. Int J Exp Pathol 95:101-19
Porta, Jason; Jose, Joyce; Roehrig, John T et al. (2014) Locking and blocking the viral landscape of an alphavirus with neutralizing antibodies. J Virol 88:9616-23
Jones-Carson, Jessica; Zweifel, Adrienne E; Tapscott, Timothy et al. (2014) Nitric oxide from IFN?-primed macrophages modulates the antimicrobial activity of ?-lactams against the intracellular pathogens Burkholderia pseudomallei and Nontyphoidal Salmonella. PLoS Negl Trop Dis 8:e3079
Phillips, Aaron T; Schountz, Tony; Toth, Ann M et al. (2014) Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses. J Virol 88:1771-80

Showing the most recent 10 out of 181 publications